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Sepsis is the systemic infl  ammatory response to 
severe microbial infection. It is well recognized 
that patients with sepsis are often immune 
suppressed, as illustrated by failure to eradicate 
their primary infections, a predisposition to 
develop secondary nosocomial infections, and 
an attenuated delayed-type hypersensitivity 
response (1, 2). Animals with polymicrobial 
sepsis also exhibit widespread dysfunction in both 
antigen-presenting cells and T lymphocytes. 
Reduced CD4+ T cell numbers caused by 
apoptosis-induced depletion (3, 4) and a sup-
pression of T cell proliferative responses (5) have 
been shown to contribute to sepsis-associated 
morbidity. Moreover, interest has focused on 
the shift from a Th1 to a Th2 cell profi  le as 
contributing to sepsis-associated immune dys-
function (6, 7).
The role that suppressor cell populations 
play in polymicrobial sepsis is unknown. The 
present study examined the role of immature 
myeloid cells in sepsis, as well as their contribution 
to the sepsis-induced defects in acquired im-
munity. Immature myeloid cells with suppressor 
functions have been previously observed in the 
spleens and tumors of mice with transplantable 
tumors (8, 9) and in models of chronic infl  am-
mation (10). In tumor-bearing mice, these cells 
contribute to tumor-associated antigen-specifi  c 
T cell dysfunction and tolerance (8, 11–15). 
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Polymicrobial sepsis alters the adaptive immune response and induces T cell suppression 
and Th2 immune polarization. We identify a GR-1+CD11b+ population whose numbers 
dramatically increase and remain elevated in the spleen, lymph nodes, and bone marrow 
during polymicrobial sepsis. Phenotypically, these cells are heterogeneous, immature, pre-
dominantly myeloid progenitors that express interleukin 10 and several other cytokines 
and chemokines. Splenic GR-1+ cells effectively suppress antigen-specifi  c CD8+ T cell 
interferon (IFN) 𝗄 production but only modestly suppress antigen-specifi  c and nonspecifi  c 
CD4+ T cell proliferation. GR-1+ cell depletion in vivo prevents both the sepsis-induced 
augmentation of Th2 cell–dependent and depression of Th1 cell–dependent antibody 
production. Signaling through MyD88, but not Toll-like receptor 4, TIR domain–containing 
adaptor-inducing IFN-𝗃, or the IFN-𝗂/𝗃 receptor, is required for complete GR-1+CD11b+ 
expansion. GR-1+CD11b+ cells contribute to sepsis-induced T cell suppression and prefer-
ential Th2 polarization.
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Splenic GR-1+CD11b+ cells may also play an instrumental 
role in the priming of B cell antibody production (16).
There has been only modest exploration of these cell 
populations in sepsis or other acute infl  ammatory processes. 
In this paper, we observed that an ongoing septic process in-
duces a dramatic expansion of the GR-1+CD11b+ popula-
tion in the bone marrow, spleen, and lymph nodes. Expansion 
of these cells was associated with splenic enlargement and 
lymphoid follicle disruption. The GR-1+CD11b+ cells con-
tained immature progenitors and expressed IL-10, TNF-α, 
and other cytokines and chemokines. Furthermore, using a 
depleting antibody, we demonstrated that expansion of GR-1+ 
cells in vivo contributed to the induced Th2 polarization of 
antibody responses after sepsis. These cells were also capable 
of causing CD8+ T cell tolerance, as demonstrated by the 
suppression of antigen-specifi  c IFN-γ production by CD8+ 
T lymphocytes in nonseptic immunized mice. Finally, we 
observed that signaling through MyD88, but not Toll-like 
receptor (TLR4), TIR domain–containing adaptor-inducing 
IFN-β (TRIF), or the IFN-α/β receptor, was required for 
the early and complete expansion of this cell population, 
highlighting the importance of infl  ammation and TLR sig-
naling other than that induced by microbial endotoxin in the 
regulation of immature myeloid cells in sepsis.
RESULTS
GR-1+CD11b+ cells accumulate in the spleen after sepsis
To examine the long-term eff  ects of polymicrobial sepsis on 
the expansion of the GR-1+CD11b+ populations, the experi-
ments were conducted in a mouse model of polymicrobial 
sepsis (generalized peritonitis) induced by ligation of the cecum 
and a double enterotomy created with a 27-gauge needle. 
Mortality in this model was  10–20% and predominantly oc-
curred during the fi  rst 96 h; thereafter, surviving mice devel-
oped abscesses surrounding the devitalized cecum. As shown in 
Fig. S1 (available at http://www.jem.org/cgi/content/full/
jem.20062602/DC1), the presence of sepsis was confi  rmed for 
at least 10 d by a transient bacteremia (lasting 24 h) and pro-
longed bacterial contamination of the peritoneal cavity. The 
animals exhibited a signifi  cant early leukopenia, followed by a 
profound granulocytosis (Fig. S2). Plasma cytokine concen-
trations over the fi  rst 10 d were consistent with an early exag-
gerated systemic infl  ammatory response and with sustained 
elevations in the plasma IL-6, KC/CXCL1, and macrophage 
infl  ammatory protein (MIP) 1β concentrations (Fig. S3).
Interestingly, surviving septic mice developed a dramatic 
splenomegaly, with the spleen mass increasing by 300% by 10 d 
after initiation of polymicrobial sepsis (Fig. S4 A, available 
at http://www.jem.org/cgi/content/full/jem.20062602/DC1). 
The dramatic increase in spleen mass suggested an expansion 
of one or more cell populations within the spleen. Periodic 
histological analysis of the spleens of mice over 10 d of sepsis 
(Fig. S4 B) demonstrated that the apparent splenomegaly was 
associated with extramedullary hematopoeisis and marked 
expansion of immature myelomonocytic cells, including forms 
with ringed nuclei in the periarteriolar sheaths and subcapsular 
space, including focal involution of lymphoid follicles. Anal-
ysis of lymphoid and nonlymphoid cell populations did not 
reveal an increase in cells expressing CD3, B220, or CD11c. 
However, a dramatic accumulation of cells expressing GR-1 
and CD11b occurred. As shown in Fig. 1 (A and B), spleno-
cytes harvested from septic mice at various intervals after ce-
cal ligation and puncture, or sham procedures, exhibited a 
striking increase in the percentages and absolute numbers of 
GR-1+CD11b+ cells. The dramatic increases in the percent-
ages and absolute numbers of GR-1+CD11b+ cells did not 
occur until at least 3 d after the induction of sepsis, and the 
percentages continued to increase to a plateau ( 7–10 d). 
The numbers and proportion of these cells remained elevated 
even out to 12 wk in surviving mice. By 10 d, the absolute 
numbers of these GR-1+CD11b+ cells in the spleen had in-
creased 50-fold.
GR-1+CD11b+ cells are phenotypically heterogenous cells
GR-1+CD11b+ cells represent a heterogenous population 
of cells encompassing mature and immature myeloid forms. 
Figure 1.  Appearance of GR-1+CD11b+ cells in spleens from septic 
and sham mice. (A) Flow cytometry dot plot of viable splenocytes gated 
on GR-1+ and CD11b+ staining. (B) Percentages and total numbers of GR-
1+CD11b+ splenocytes recovered from mice at intervals after CLP and 
sham treatment. (C) Percentages and total numbers of GR-1+CD11b+CD31+ 
splenocytes recovered from mice at intervals after CLP and sham treat-
ment. Sepsis induced by CLP produced 50-fold increases in numbers of 
GR-1+CD11b+ splenocytes. The dashed lines represent the percentages of 
GR-1+CD11b+ cells (B) and the percentages of GR-1+CD11b+CD31+ cells 
(C) in control animals that are neither sham nor CLP treated. Values repre-
sent the mean and standard error of 5–10 animals per group. *, P < 0.01 
by analysis of variance and the Student-Newman-Keuls multiple range 
test. CLP, cecal ligation and puncture.JEM VOL. 204, June 11, 2007  1465
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To further characterize these GR-1+CD11b+ cells, spleno-
cytes were also stained for CD31, a marker of immature 
myeloid development that is lost with more terminal cell dif-
ferentiation (17), and Ter119, a marker of erythroid lineage, 
as well as F4/80, a marker for myeloid lineage development. 
As shown in Fig. 1 C,  40% of the GR-1+CD11b+ cells 
were also CD31+, and the numbers of GR-1+CD11b+CD31+ 
cells were increased nearly 70-fold during sepsis. Similar results 
were obtained examining the GR-1+CD11b+F4/80+ triple-
positive cells in the spleen and bone marrow (unpublished 
data), suggesting that the GR-1+ cells contained a subpopu-
lation of developing myeloid cells. In contrast, only 6% of the 
GR-1+CD11b+ cells were Ter119+, suggesting that only a 
small proportion of these cells may still possess the ability to 
diff  erentiate into cells of erythroid lineage (Fig. S5, available 
at http://www.jem.org/cgi/content/full/jem.20062602/DC1). 
Interestingly, however, <3% of these GR-1+CD11b+ cells 
were also MHC class II+ (Fig. S6).
As shown in Fig. 2 D, the enriched GR-1+ cell population 
from the spleens of septic mice contained large numbers of 
phenotypically heterogeneous cells. Many of these cells had 
characteristic circular or ringed-shaped nuclei. Gauging on 
their nuclear size, complexity, and cytoplasmic granularity as 
described previously in the literature, most of these cells were 
determined to be immature myeloid forms (18). These cells 
were identifi  ed on the cell-sorted cytospin preparations.
To examine whether the GR-1+CD11b+ population were 
an immature proliferating precursor population sensitive to 
myeloid growth factors, the GR-1+–enriched splenocytes 
from septic mice were cultured ex vivo on 24-well plates with 
GM-CSF. In the absence of GM-CSF, these cells rapidly 
died. In contrast, 7 d of culture with GM-CSF led to  17% 
of these cells diff  erentiating into conventional CD11chighMHC 
class IIhigh dendritic cells and  22% diff  erentiating into F4/
80high macrophages (Fig. 2, A–C), and all of these cells 
demonstrated increased MHC class II expression over freshly 
isolated Gr-1+CD11b+ cells. In addition, culturing these 
GR-1+ cells from septic mice in soft methylcellulose with 
  either GM-CSF or G-CSF, but not erythropoietin, for 7 d led 
to an increase in the number of colonies formed (Fig. 2 E). 
Interestingly, the GR-1+ cells from sham-treated mice did 
not contain any signifi  cant number of progenitors capable of 
forming colonies in response to these growth factors. The 
failure of GR-1+ cells from septic mice to generate a signifi  -
cant number of colonies in response to erythropoietin and 
the low Ter119+ staining suggest that during sepsis, these 
Figure 2.  Flow cytometric analysis of GR-1+ splenocytes cultured 
with GM-CSF, G-CSF, or erythropoietin ex vivo. (A) Flow cytometric 
analysis of enriched GR-1+ splenocytes obtained from septic mice 10 d 
after CLP. (B) Cells were cultured for 7 d with media alone or media and 
GM-CSF, and cell viability was determined by 7-amino-actinomycin D 
staining. Cells cultured without GM-CSF rapidly died. (C) GR-1+–enriched 
splenocytes cultured with GM-CSF for 7 d yielded a phenotypically diverse 
cell population staining positive for CD11c and F/480. (D) Cytospin prepa-
ration of enriched GR-1+ cells 10 d after CLP demonstrated immature 
heterogeneous myeloid phenotypes with characteristic ring shaped nuclei. 
Bar, 5 μm. (E) Colony-forming units of GR-1+–enriched splenocytes cul-
tured with G-CSF, GM-CSF, or EPO for 10 d in soft methylcellulose. The 
images distinguish the nature of the colonies, refl  ecting primarily neutro-
phil- and monocyte-like colonies in the G-CSF– and GM-CSF–treated 
groups, respectively. Bars, 15 μm. Values in A–C represent the mean and 
standard error of 5–10 animals per group, and the numbers in the quad-
rants represent the percentage of cells in that quadrant based on the 
total number of cells that were gated. Horizontal lines indicate the mean 
number of colonies per group. CLP, cecal ligation and puncture; EPO, 
erythropoietin; MNC, mononuclear cell; PMN, polymorphonuclear.1466  IMMATURE MYELOID CELLS IN SEPSIS | Delano et al.
expanded numbers of GR-1+CD11b+ cells represent a mixed 
population of immature, proliferating, progenitors committed 
predominantly to a myeloid, and not an erythroid, pathway.
Immature myeloid cells accumulate in secondary lymphoid 
organs after sepsis
We also looked for these GR-1+CD11b+ cells in other sec-
ondary lymphoid and reticuloendothelial organs. For these 
cross-sectional analyses, we selected intervals after cecal liga-
tion and puncture or a sham procedure when the changes 
in the spleen were maximal. No signifi  cant increases in 
GR-1+CD11b+ cells were seen in either the liver or lung 
(unpublished data). In peripheral lymph nodes, however, 
marked increases in the percentages and numbers of these 
GR-1+CD11b+ cells were evident at 10–14 d after sepsis and 
were still increased at 12 wk (Fig. 3, B and C). Numbers re-
mained signifi  cantly elevated in mesenteric lymph nodes in 
direct proximity to the cecal ligation and puncture at 12 wk, 
whereas numbers declined somewhat, but still remained sig-
nifi  cantly elevated, in more distal inguinal and axillary lymph 
nodes at 12 wk. In the bone marrow (Fig. 3 A), the numbers 
of these GR-1+CD11b+ cells doubled within 3 d and ac-
counted for nearly 90% of the cells by 7 d after sepsis.
Histological confi  rmation of these cells in the spleens of 
mice with severe sepsis is shown in Fig. 4 (A–C). Over the 
course of 10 d, there was progressive expansion of the red 
pulp by extramedullary hematopoiesis and marked expan-
sion of the periarteriolar sheaths (Fig. 4 B) and subcapsular 
space (Fig. 4 C) by immature mononuclear cells and myelo-
monocytic cells with ringed nuclei. These cells were also 
found in small clusters within the interfollicular areas. The 
immature myeloid cells with ringed nuclei in all of these lo-
cations were uniformly CD11b+ in the spleens of mice that 
underwent cecal ligation and puncture (Fig. 4, D, F, and G). 
In contrast, CD11b showed only scattered reactivity in the 
sham-treated mice, mainly highlighting mature granulocytes 
within the interfollicular areas (Fig. 4 E). The increasing 
numbers and overall percentage of immature myelomono-
cytic cells with ringed nuclei correlated with the time pro-
gression after sepsis and was associated with cuffi   ng in the 
perivascular/periarteriolar sheaths and subcapsular spaces. 
Finally, there was focal involution of the lymphoid follicles 
that paralleled the expansion of the red pulp. No immature 
myelomonocytic cells with ringed nuclei were identifi  ed 
within the follicular areas.
Immature myeloid cells are capable of infl  ammatory 
mediator production
Because immature myeloid cells obtained from tumor-bearing 
hosts are known to be immunomodulatory (8, 9), we next 
examined whether cells obtained from septic mice could 
produce infl  ammatory mediators, including IL-10, a cytokine 
generally regarded as a requisite for T cell suppression and 
Th2 cell polarization during sepsis. When GR-1+–enriched 
splenocytes from septic mice were cul tured ex vivo, they pro-
duced low levels of several infl  ammatory mediators,   including 
IL-10, TNF-α, regulated on activation, normal T cell ex-
pressed and secreted (RANTES; CC chemokine ligand 5), 
and MIP-1β (CC chemokne ligand 4). When stimulated ex 
vivo with bacterial LPS, the GR-1+ cells from septic mice 
produced signifi  cantly greater amounts (more than fi  vefold) 
of IL-10 than similar GR-1+ cells from sham-treated animals 
(Fig. 5). They also produced increased quantities of TNF-α, 
RANTES, and MIP-1β but did not produce the Th2 cyto-
kines IL-4 or IL-13. Unstimulated or LPS-stimulated GR-1+ 
splenocytes did not produce measurable quantities of GM-
CSF, IL-12p40, IL-12p70, IL-2, IL-3, IL-5, IL-9, IL-17, 
vascular endothelial growth factor, or IFN-γ (unpublished data). 
In addition, GR-1+ splenocytes obtained from septic mice 
also produced TNF-α (218 ± 67 vs. 4 ± 1 pg/ml) and IL-10 
Figure 3.  Bone marrow and lymph node GR-1+CD11b+ cells from 
septic and sham mice. CLP produced a rapid increase in the numbers of 
GR-1+CD11b+ cells in the bone marrow (A) and lymph nodes (B and C). A 
sham procedure produced a more transient modest increase. Values rep-
resent the mean and standard error of 5–10 animals per group. Dashed 
line indicates the mean percentage from healthy control animals not 
subjected to CLP or sham procedures. *, P < 0.01 between CLP and sham-
treated animals by the Student’s t test. CLP, cecal ligation and puncture.JEM VOL. 204, June 11, 2007  1467
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(165 ± 43 pg/ml) in response to stimulation with 5 μg/ml 
fl   agellin (TLR5 agonist), albeit in lesser quantities than 
with LPS stimulation.
Immature myeloid cells affect adaptive immune responses 
in sepsis
To examine whether these cells could affect adaptive 
immune function, sham-treated and septic mice were immu-
nized with 4-hydroxy-3-nitrophenyl acetyl–KLH (NP-KLH) 
using the adjuvant alum when GR-1+ cells reached a maxi-
mal proportion in the spleen (10 d after cecal ligation and 
puncture), and the NP-specifi  c serum immunoglobulin re-
sponse was determined 10 d later. The serum immunoglobu-
lin response to NP-KLH with alum is a T cell–dependent, 
B cell response, and the immunoglobulin isotypes can be used 
to assess polarization of the T cell response (19). Polymicro-
bial sepsis was not associated with any signifi  cant changes in 
total IgM or IgG responses (Fig. 6, A and B); however, when 
the total IgG response was dissected into its isotypic compo-
nents, the serum IgG2a response was signifi  cantly decreased 
Figure 4.  Hematoxylin and eosin–stained spleens from septic mice 
10 d after CLP. (A) Low power view, with the perivascular region identi-
fi  ed (inset). (B) High power view of the perivascular region showing cuff-
ing and infi  ltration, with myeloid cells showing characteristic ring 
features (black arrows). Note the mitotically active cell (white arrow). 
(C) High power view of the subcapsular region also showing infi  ltration, 
with myeloid cells exhibiting characteristic ring features (arrows). (D) CD11b+ 
staining of the spleen from a septic animal 10 d after CLP. (E) CD11b+ 
staining of the spleen from a sham-treated animal 10 d after surgical 
procedure. In the sham animal, CD11b+ staining is distributed in the man-
tel region surrounding T cell–rich follicles. After 10 d of sepsis, additional 
CD11b+ staining appears in the perivascular and subcapsular regions. 
(F) High power view of staining of the perivascular region showing 
CD11b+ staining from a 10-d septic animal. (G) High power view showing 
resolution of the subcapsular region showing CD11b+ staining from a 
septic animal. Bars, 100 μm. CLP, cecal ligation and puncture.
Figure 5.  Effect of ex vivo LPS stimulation on cytokine expression 
in GR-1+ splenocytes obtained from septic mice. When GR-1+ sple-
nocytes were harvested from 7-d sham-treated or septic mice and stimu-
lated with 10 μg/ml of bacterial LPS, IL-1α, IL-1β, IL-6, IL-10, TNF-α, 
RANTES, MIP-1β, and KC/CXCL1 production was signifi  cantly increased in 
all groups stimulated with LPS. Importantly, GR-1+ splenocytes from 
septic mice secreted more IL-10, TNF-α, RANTES, and MIP-1β production 
after LPS administration than GR-1+ splenocytes from sham-treated 
animals. Values represent the mean ± SEM of between four and six sam-
ples. *, P < 0.05 by the Student’s t test.1468  IMMATURE MYELOID CELLS IN SEPSIS | Delano et al.
while the IgG1 response increased in the septic mice, consistent 
with a shift from a Th1 to a Th2 response (Fig. 6, C and D). 
When the septic mice were treated with a GR-1–depleting 
antibody, producing >80% reduction in total GR-1+CD11b+ 
splenocytes (Fig. S7, available at http://www.jem.org/cgi/
content/full/jem.20062602/DC1), the sepsis-induced in-
crease in IgG1 and the decrease in IgG2a responses were 
abolished, demonstrating the involvement of the GR-1+ 
cells in this polarization. As expected by the T cell–depen-
dent nature of this antibody response, depletion of CD4+ 
cells signifi  cantly attenuated the IgM responses and com-
pletely prevented the IgG class switching in the septic animals 
(Fig. S8, A–D).
To further confi  rm the in vivo role that these cells play 
in suppressing an antigenic T cell response, the eff  ect of 
GR-1+ cells on the CD8+ T cell IFN-γ response by sple-
nocytes from OT-I TCR transgenic mice (C57BL/6-
Tg(TCRαTCRβ)1100mjb/J) immunized with OVA-derived 
peptide (H-2Kb restricted, aa 257–264; SIINFEKL) was ex-
amined (Fig. 7 A). GR-1+ cells obtained from either 10-d 
septic or sham-treated mice were infused into C57BL/6 mice 
that had previously received CD8+ T cells from OT-1 TCR 
transgenic mice, and mice were simultaneously immunized 
with OVA-derived specifi  c peptide. 10 d later, the spleens 
from these animals were removed, and IFN-γ responses to ex 
vivo stimulation with OVA-derived specifi  c peptide were 
examined. IFN-γ production was markedly reduced when 
the animals were administered GR-1+ splenocytes from septic 
animals when compared with sham-treated mice, confi  rming 
that GR-1+ splenocytes from these septic mice could suppress 
a CD8+ T cell IFN-γ response.
To determine whether GR-1+ cells could directly suppress 
an antigen-specifi  c or nonspecifi  c CD4+ T cell proliferative 
response, DO11.10 OVA-TCR transgenic mice were made 
septic, and CD4+ splenocytes were cultured with irradiated 
GR-1+–containing antigen-presenting cells from the spleens 
of 10-d septic or sham-treated mice and were incubated with 
either OVA peptide, bovine serum albumin, or on CD3/CD28-
coated plates. As shown in Fig. 7 B, culturing CD4+ cells with 
irradiated GR-1+ cells from septic mice only modestly, but 
still signifi  cantly, reduced both the antigen-specifi  c (OVA) 
and nonspecifi  c (CD3/CD28) proliferative responses.
MyD88 signaling pathways are required for GR-1+CD11b+ 
cells to accumulate in the spleen after polymicrobial sepsis
Polymicrobial sepsis produced by cecal ligation and puncture 
releases a large number of microbial products that are recog-
nized by the innate immune system, in large part through TLR 
signaling pathways. To examine the cell signaling pathways 
required to elicit the expansion of these immunomodulatory 
GR-1+CD11b+ cells, wild-type C57BL/6 mice were injected 
with a sublethal dose (5 mg/kg body weight) of the TLR4 
agonist bacterial LPS. The numbers of these GR-1+CD11b+ 
splenocytes were examined at daily intervals after LPS in-
jection. As shown in Fig. 8 A, the administration of bacterial 
LPS produced a more rapid but transient increase in the 
percentages and absolute numbers of GR-1+CD11b+ sple-
nocytes, suggesting that the likely pathway involves TLR4 
Figure 6.  Ig production after NP-KLH immunization in sham mice, 
septic mice, and septic mice depleted of GR-1+ cells. 9 and 10 d 
after induction of sepsis by CLP, mice were depleted of GR-1+ cells by the 
i.p. administration of RB6-8C5 anti-GR-1 antibody, as described in Mate-
rials and methods. Mice were then immunized with NP-KLH. 7 d later, 
mice were bled, and serum IgM (A), total IgG (B), IgG1 (C), and IgG2a (D) 
responses to NP-KLH immunization were determined. Sepsis produced no 
difference in the IgM response while concomitantly producing an increase 
in the total serum IgG and IgG1 and a decrease in the serum IgG2a re-
sponse consistent with Th2 polarization. The total IgG, IgG1, and IgG2a 
responses after sepsis were prevented by depletion of the GR-1+ cells. 
Horizontal lines represent the means for each group of samples. *, P < 
0.01 by analysis of variance and the Student-Newman-Keuls multiple 
range test. CLP, cecal ligation and puncture.JEM VOL. 204, June 11, 2007  1469
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signaling. The expansion of GR-1+CD11b+ splenocytes by 
LPS occurred by 24 h, reached a peak by 5 d, and declined 
thereafter until it reached a near-baseline level by day 10. In-
terestingly, the increased number of splenic GR-1+CD11b+ 
cells was very modest compared with mice undergoing cecal 
ligation and puncture, and even the sham procedure produced 
some modest increase in GR-1+CD11b+ cell numbers.
To determine whether TLR4 signaling is a requirement 
for the expansion of these cell populations in our model of 
polymicrobial sepsis, cecal ligation and puncture was per-
formed in C3H/HeJ mice that have a spontaneous mutation 
in TLR4, and the results were compared with C3H/OuJ 
mice. As shown in Fig. 8 B, TLR4 mutant C3H/HeJ mice 
had a comparable increase in splenic GR-1+CD11b+ cell 
number as the C3H/OuJ controls at 7 d, suggesting that in-
tact TLR4 signaling is not required for the expansion of these 
GR-1+CD11b+ cells in sepsis. Thus, although LPS signaling 
via TLR4 can induce an expansion of this GR-1+CD11b+ 
cell population, TLR4 signaling is not required during poly-
microbial sepsis, and there are redundant signaling pathways.
Such fi  ndings are not completely unexpected, because 
polymicrobial sepsis is generally associated with the release 
of large numbers of diff  erent microbial products that can si-
multaneously signal through several diff  erent TLR receptors. 
Because TLR signaling occurs through MyD88- and TRIF-
dependent pathways and may involve the secretion of type I 
IFNs, cecal ligation and puncture were also performed in 
MyD88−/−, TRIF−/−, and IFN-α/βR−/− mice. The in-
creased expansion of GR-1+CD11b+ cells after cecal ligation 
and puncture at 7 d was markedly attenuated in only the 
MyD88−/− (B6 × 129) mice and not in either the TRIF−/− 
or IFN-α/βR−/− mice, highlighting the requirement of 
MyD88 signaling for the early expansion of this cell popula-
tion during sepsis (Fig. 8, C–E).
To confi  rm that the requirement for MyD88 signaling 
was not dependent on the background of the animals and was 
sustained during prolonged sepsis, the studies were repeated 
in MyD88−/− animals backcrossed onto a C57BL/6 back-
ground. As shown in Fig. 9, after 7 d of sepsis, there was 
again no expansion of the GR-1+CD11b+ population in the 
MyD88−/− (B6) mice. By 14 d, there was some expansion of 
the GR-1+CD11b+ cell populations, but it was still markedly 
attenuated when compared with the wild-type B6 controls.
D  I  S  C  U  S  S  I  O  N 
T cell dysfunction is a common response to polymicrobial 
sepsis (1), ultimately leading to increased susceptibility to 
ongoing and opportunistic infections and poor outcome. 
Recent attention has focused on the shift from a more proin-
fl  ammatory Th1 to a more antiinfl  ammatory Th2 cell im-
mune profi   le as an explanation for postsepsis immune 
suppression; however, the underlying mechanisms that or-
chestrate this T cell suppression and Th2 cell polarization dur-
ing sepsis are still unknown.
Although there has been some speculation that endoge-
nous and inducible T regulatory cells may contribute to the 
T cell suppression and Th2 polarization in sepsis (20, 21), more 
recent studies have refuted some of those claims (22, 23). 
Several years ago, Murphey et al. observed an increased num-
ber of macrophage-like cells in the spleens of mice surviving 
cecal ligation and puncture (5), although they did not explore 
their suppressor cell function. More recently, Makarenkova 
et al. observed increased numbers of immature myeloid cells 
in the spleens of mice within 12 h of a traumatic injury and 
identifi  ed them as a source of arginase I activity (24).
Using a model of polymicrobial sepsis that produces only 
limited early mortality but sustained infl  ammation, as deter-
mined by elevated plasma cytokine concentrations and neu-
trophilia, we observed a profound splenomegaly that persisted 
for weeks in surviving animals. On closer examination, it 
Figure 7.  Effect of GR-1+ cells from septic mice on antigen-
specifi  c CD4+ T cell proliferation and CD8+ T cell IFN-𝗄 responses. 
Mice were treated as described in Materials and methods. GR-1+ cells 
from septic animals markedly attenuated the IFN-γ production (deter-
mined by ELISPOT) by OT-1 splenocytes stimulated with either control 
peptide or OVA-derived peptide SIINFEKL ex vivo after administration and 
immunization in C57BL/6 mice (A). In contrast, GR-1+ splenocytes from 
10-d septic mice had only a minimal but signifi  cant suppressive effect on 
antigen-specifi  c and nonspecifi  c CD4+ T cell proliferative responses in 
OVA antigen-specifi  c, DO11.10 mice (B). Values represent the mean and 
standard error of fi  ve animals per group. The experiment was repeated 
twice, and the values presented are from one representative experiment. 
*, P < 0.05 by analysis of variance and the Student-Newman-Keuls mul-
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  became evident that, in association with this ongoing septic 
process, there was marked disintegration of the follicular re-
gions, increased extramedullary hematopoiesis, and replace-
ment of the splenic cellularity with large numbers of immature 
myeloid cells (Fig. 1). Hotchkiss and co- workers, as well as 
us, had previously shown that, in similar models of polymi-
crobial sepsis, there is a rapid apoptotic loss of CD4+ T cells 
and dendritic cells in the fi  rst 24 h of sepsis and that these cel-
lular losses contribute to the adverse outcome (25–27). Al-
though there has been considerable exploration into the role 
of extramedullary hematopoiesis in chronic infectious and 
infl  ammatory processes, none have explored or even described 
this massive expansion of an immature myeloid cell popula-
tion (GR-1+CD11b+CD31+) in the bone marrow, spleen, 
and lymph nodes of mice with ongoing septic processes. We 
have clearly shown that by 10 d after cecal ligation and punc-
ture, almost 40% of the spleen and 90% of the bone marrow 
cellularity represent immature GR-1+CD11b+ cells. Inter-
estingly, the administration of near lethal doses of bacterial 
LPS could also produce some expansion of this immature 
myeloid cell population. However, the increases were tran-
sient and modest compared with those seen in the septic ani-
mals, suggesting that an ongoing infl  ammatory process may 
be required for complete manifestation of the response (10).
The phenotype of these cells, the kinetics of their expan-
sion, and their anatomical location in the spleen argue against 
them being functionally or phenotypically similar to those 
reported previously by Makarenkova et al. (24) immediately 
after trauma, or as mere components of extramedullary he-
matopoiesis. Makarenkova et al. observed a rapid infl  ux of 
GR1+CD11b+ cells into the spleens of mice 12–24 h after 
traumatic injury. However, these cells, which produced large 
quantities of arginase I, were located in the mantle surround-
ing the lymphocyte-rich follicles, and very few ring cells 
were detected. In contrast, we saw a transient decline in 
GR1+CD11b+ splenocytes during the fi  rst 24 h of sepsis and 
only saw expansion of our splenocyte population after 3–5 d 
of sepsis. Furthermore, although both populations are clearly 
heterogenous, our cells contained higher proportions of 
immature precursors that were concentrated in perivascular/
periarteriolar and subcapsular regions of the spleen, exhibited 
less MHC class II expression, and made copious amounts of 
IL-10 when stimulated ex vivo. These cells obtained from 
the spleens of septic animals contained predominantly pre-
cursors committed to a myeloid and not erythroid lineage. 
Less than 6% of the GR-1+CD11b+ cells recovered from the 
spleens of septic mice were Ter119+ and, when cultured in 
soft methylcellulose with erythropoietin, had only a minimal 
Figure 8.  Effects of LPS and transgenic mice on the expansion of 
the splenic GR-1+CD11b+ population 7 d after CLP. (A) Mice received 
either nothing or the i.p. injection of 5 mg/kg body weight of bacterial 
LPS and were killed at intervals thereafter. LPS injection increased the 
percentage of GR-1+CD11b+ cells in the spleen within 1 d, and expansion 
of this cell population remained for about 7 d. CLP was induced in C3H/
HeJ (TLR4 mutant; B), IFN-α/βR−/− (C), MyD88−/− (B6 × 129; D), and 
TRIF−/− (E) mice, as described in Materials and methods. 1 and 7 d later, 
splenic GR-1+CD11b+ populations were examined in the spleens of 
knockout mice and their appropriate background controls. Normal expan-
sion of the GR-1+CD11b+ splenocytes was seen in all mice at 7 d, with 
the exception of the MyD88−/− mice that failed to demonstrate an in-
crease in their GR-1+CD11b+ population. Values represent the mean and 
standard error of fi  ve animals per group. *, P < 0.01 versus control at the 
same time point, as determined by the Student’s t test. CLP, cecal ligation 
and puncture.JEM VOL. 204, June 11, 2007  1471
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capacity for colony or burst formation (Fig. S5). In contrast, 
almost 40% of the cells diff  erentiated into macrophages or 
dendritic cells when cultured with GM-CSF (Fig. 2 C), and 
large numbers were capable of forming colonies when in-
cubated in soft methylcellulose with either G-CSF or GM-
CSF (Fig. 2 E).
This dramatic expansion of the GR-1+CD11b+ response 
to sepsis in the spleen is very similar to the response previ-
ously observed in mice with actively growing tumors. Similar 
immature myeloid cell populations have been shown to ac-
cumulate in the spleens, infi  ltrating into tumors in several an-
imal tumor models (11–15), and also in the blood of some 
patients with cancer (28). In mice with transplantable tumors, 
these myeloid-derived suppressor cells, as they are now being 
termed (29), have also been shown to inhibit antigen-specifi  c 
and nonspecifi  c T cell functions via several diff  erent mecha-
nisms, including arginase I, nitric oxide, reactive oxygen spe-
cies, and TGF-β.
Given the abilities of immature myeloid cells to facilitate 
immune suppression in mouse cancer models, as well as to 
suppress antigen-specifi  c T cell responses and to infl  uence B 
cell antibody production, the expansion of these immature 
myeloid populations in sepsis may similarly orchestrate the 
Th1 to Th2 immune polarization that is known to occur in 
sepsis. Challenging mice with T cell– dependent antigens, 
such as NP-KLH, off  ers the opportunity to explore in vivo 
the shift in antibody class switching to IgG2a or IgG1 produc-
tion, which is dependent on cytokines, including IFN-γ and 
IL-4, and refl  ects this predilection toward a Th2 versus a Th1 
CD4+ T cell response (16, 19). 10 d after sepsis, immuniza-
tion with NP-KLH led to an increase in the IgG1 production 
at the expense of IgG2a, consistent with a preferential Th2 
  response. In contrast, partial depletion of the GR-1+ cells in 
vivo blocked the characteristic increase in the IgG1 secretion 
while also preventing the fall in the IgG2a responses, demon-
strating a contributory role for these GR-1+ cells in this shift 
from a Th1 to Th2 response.
Consistent with these fi  ndings was the observation that 
GR-1+ cells from septic mice substantially attenuated the 
IFN-γ response by CD8+ T cells to specifi  c antigenic stimu-
lation. These results are very similar to the suppression of cy-
totoxic T cells to antigen-specifi  c stimulation by GR-1+ cells 
obtained from tumor-bearing hosts (11). Surprising, how-
ever, were the modest reductions in antigen-specifi  c CD4+ 
T cell proliferation that we observed when GR-1+ cells were 
cultured with DO11.10 CD4+ OVA transgenic T cells im-
munized with OVA peptide. The answer may simply be that 
these GR-1+ cells express very little MHC class II, whereas 
they retain relatively high levels of MHC class I expression (11). 
Therefore, in the DO11.10 CD4+ OVA transgenic mouse 
model, these GR-1+ cells were probably unable to present 
antigen via MHC class II and, therefore, could not directly 
aff  ect CD4+ T cell proliferative responses. In contrast, they 
could present antigen in the context of class I expression and 
suppress CD8+ T cell IFN-γ responses.
Interestingly, the numbers of immature myeloid cells 
decreased in mice in which the abscess had spontaneously 
resolved 12 wk after sepsis (unpublished data). Furthermore, 
when these same animals with abscess resolution were immu-
nized with NP-KLH and alum, the antibody response more 
closely approximated baseline isotype levels (Fig. S9, available 
at http://www.jem.org/cgi/content/full/jem.20062602/DC1). 
Similar decreases in the numbers of immature myeloid cells 
have been reported in tumor-bearing animals upon resection 
of their primary tumor (30).
The similarities in the appearance of these myeloid-
derived suppressor cells in sepsis and in animals with tumors 
or other chronic infl  ammatory processes suggest that there 
are common signals involved in the expansion of these cell 
populations. Polymicrobial sepsis produced by a ligation and 
puncture of the cecum releases large quantities of microbial 
products into the peritoneum and systemic circulation. It is 
not at all surprising that polymicrobial sepsis produced a 
comparable expansion of the GR1+CD11b+ population in 
C3H/HeJ mice lacking a functional TLR4 receptor, suggest-
ing that although LPS contributes to the septic response in 
wild-type mice, signaling through TLR4 is not required 
during polymicrobial sepsis, as signaling through other TLRs by 
pathogen-associated molecular patterns likely also contributes 
to the expansion of these cell populations. Considering the 
fact that mice with defective TLR4 signaling also exhibit 
mortality comparable with wild-type mice after sublethal 
polymicrobial sepsis (31), the fi  ndings suggest that neither 
mouse expansion of myeloid-derived suppressor cells nor 
survival after sepsis are entirely TLR4 dependent.
Two major pathways activated by TLR signaling include 
the induction of both infl   ammatory mediators through 
MyD88 and type I IFN production. Because both MyD88 
Figure 9.  Requirement for MyD88−/− signaling in the expansion 
of GR-1+CD11b+ splenocytes in response to prolonged sepsis. 
MyD88−/− mice on a C57BL/6 background and wild-type controls under-
went CLP, and the representative animals were killed at 7 and 14 d after 
induction of sepsis. The relative and absolute numbers of GR-1+CD11b+ 
splenocytes were determined, as previously described in Fig. 1. As seen in the 
MyD88−/− B6 × 129 animals, there was no increase in the GR-1+CD11b+ 
splenocyte population 7 d after sepsis. However, there was an increase in the 
GR-1+CD11b+ population at 14 d, although it was modest compared with 
the wild-type animals. *, P < 0.01 versus control at the same time point, 
as determined by the Student’s t test. CLP, cecal ligation and puncture.1472  IMMATURE MYELOID CELLS IN SEPSIS | Delano et al.
and TRIF pathways can lead to type I IFN production, mice 
defi  cient in the type I IFN receptor were used to ascertain 
the role of type I IFN in sepsis-induced myeloid cell accu-
mulation. The increases in the GR1+CD11b+ population 
were unaff  ected in mice lacking TRIF or IFN-α/βR signal-
ing, indicating that TLR signaling to type I IFNs is not im-
portant in the induction of these cells. However their 
expansion was completely prevented for the fi  rst 7 d in septic 
mice lacking MyD88 signaling and was still considerably at-
tenuated after 14 d. The studies were confi  rmed in MyD88−/− 
mice on two backgrounds (B6 and B6 × 129(F1)) to ensure 
that these fi  ndings were not strain dependent. This observa-
tion, in particular, suggests that the expansion of this cell 
population represents a fundamental component of infl  am-
matory signaling in the host innate immune response to TLR 
ligation by pathogens. In response to microbial products re-
leased during cecal ligation and puncture, activation of in-
fl  ammatory signaling through MyD88, presumably through 
ligation of multiple TLR receptors, plays a key role in the 
expansion of these cell populations.
In summary, the results demonstrate for the fi  rst time that 
the numbers of GR-1+ CD11b+ cells increase dramatically in 
the spleen, lymph nodes, and bone marrow during polymi-
crobial sepsis and remain elevated for up to 12 wk. These 
cells are heterogenous, metabolically active, can secrete sev-
eral cytokines, and are immature, but they are predominantly 
committed to development along myeloid pathways. Signal-
ing through MyD88 is required for the complete expansion 
of these cell populations, with an incomplete increase in the 
numbers of these cells in the spleen or bone marrow in the 
absence of MyD88 signaling. In mice, these cells contribute 
to the T cell suppression seen after sepsis by suppressing 
CD8+ T cell IFN-γ production, and to the polarization from 
a Th1 to a Th2 immune response exhibited by augmenting B 
cell antibody production toward IgG1 (Th2) and away from 
IgG2a (Th1). What remains unresolved is whether a compa-
rable expansion of these immature myeloid populations also 
occurs in human sepsis and contributes to the immune sup-
pression and polarization that occurs. Further studies will be 
required to determine whether these fi  ndings translate to a 
better understanding of the human innate and adaptive im-
mune responses to severe sepsis.
MATERIALS AND METHODS
Mice. All experiments were approved by the Institutional Animal Care and 
Use Committees at the University of Florida College of Medicine, Rhode 
Island Hospital and Brown University, or Schering-Plough Biopharma. 
Specifi  c pathogen-free C57BL/6 mice, C3H/HeJ mice (TLR4 receptor 
mutation) and their control mice (C3H/HeOuJ), OT-1 TCR transgenic 
mice (C57BL/6-Tg(TCRαTCRβ)1100Mjb/J), DO11.10 OVA TCR 
transgenic mice (BALB/c-TgN(DO11.10)10Loh), and B6.129PF1/J mice 
were all purchased from the Jackson Laboratory. IFN-αβR/A129 mice on 
the 129S6/SvEv background (H-2b) and wild-type Sv129 mice were pur-
chased from B&K Universal. All mice were maintained at the University of 
Florida College of Medicine. MyD88−/− mice on a B6 × 129(F1) back-
ground and TRIF−/− mice were a gift of S. Akira (Hyogo College of Medi-
cine, Hyogo, Japan) to Schering-Plough Biopharma and were maintained 
at Schering-Plough Biopharma. MyD88−/− mice on a B6 background were 
obtained from S. Akira and were maintained at Rhode Island Hospital and 
Brown University.
Cecal ligation and puncture. For induction of polymicrobial sepsis, mice 
underwent cecal ligation and puncture or a sham procedure, as previously 
described (4, 32), to obtain a mortality of 10–20% by 10 d. At various inter-
vals, bacterial counts from the blood and peritoneal wash (3 ml of phosphate-
buff  ered saline) were determined by culturing aliquots on sheep RBC–agar 
plates. Total and diff  erential white blood cell counts were also determined 
using an automated cell counter (Hemavet 1700 FS; Drew Scientifi  c Inc.). 
Plasma cytokines were determined by Luminex technology (Beadlyte Mouse 
Multi-Cytokine Detection System; Upstate Cell Signaling Solutions).
Flow cytometry. Spleens, lymph nodes, and bone marrow cells were ana-
lyzed by fl  ow cytometry, as previously described (32). Antibodies included 
anti–GR-1 (Ly-6G and Ly-6C; clone RB6-8C5) conjugated to allophycocy-
anin (APC), anti-CD11b (integrin αM chain, Mac-1α chain; clone M1/70) 
conjugated to FITC, anti–MHC class II (I-A/I-E; 2G9) conjugated to FITC, 
anti-F4/80 antigen (panmacrophage marker; clone BM8) conjugated to PE, 
Ter119 conjugated to FITC (clone ter119), anti-CD11c (clone N418) con-
jugated to APC, Fc-Block (CD16/CD32 Fc g III/II receptor; 2.4G2), and 7-
amino-actinomycin D F4/80- and CD11c-specifi   c antibodies purchased 
from eBioscience; all other antibodies were purchased from BD Biosciences.
Cell purifi  cation. All magnetic bead kits were obtained from Miltenyi 
Biotec. Erythrocyte-depleted splenocytes and lymphocytes were iso-
lated using either anti–GR-1 (Ly6-G and Ly-6C; clone RB6-8C5) con-
jugated to APC followed by anti-APC MicroBeads for GR-1+ 
splenocytes. Anti-CD8a (Ly-2) MicroBeads were used alone for OT-1 
CD8+ splenocyte isolation.
Ex vivo stimulation and cytokine production. Enriched GR-1+ cells 
were plated at 106 cells/well with RPMI 1640 supplemented with 10% fetal 
calf serum, 2 mM l-glutamine, 200 U/ml penicillin, and 50 μg/ml strepto-
mycin, and stimulated with 10 μg/ml of bacterial LPS (Escherichia coli 0111:
B4). The culture supernatant was analyzed for cytokines.
Ex vivo diff  erentiation and colony formation. 106 GR-1+ splenocytes 
were positively enriched and cultured with RPMI 1640 medium supple-
mented with 10% fetal calf serum, 2 mM l-glutamine, 200 U/ml penicillin, and 
50 μg/ml streptomycin. Cells were stimulated for 7 d with 10 ng/ml GM-CSF 
(R&D Systems). The cells were phenotyped by fl  ow cytometric analyses.
For the colony-forming assays, 105 GR-1+ splenocytes from sham and 
septic mice were cultured in Methocult methylcellulose media (StemCell 
Technologies Inc.) containing recombinant mouse G-CSF, GM-CSF, or 
erythropoeitin (all at 10 ng/ml; R&D Systems) for 10 d. Colonies containing 
>30 cells were enumerated.
Antigen-specifi  c CD8+ T cell IFN-𝗄 production. 3–5 × 106 purifi  ed T 
cells from OT-1 TCR transgenic mice were injected i.v. into naive C57BL/6 
recipient mice. 2 d later, mice were injected i.v. with 5 × 106 GR-1+ cells 
obtained 10 d after sepsis or sham procedure. Mice were immunized s.c. with 
the specifi  c peptide (100 μg of the OVA-derived peptide SIINFEKL) mixed 
with incomplete Freud’s adjuvant. 10 d later, lymph node and spleen cells 
were isolated and restimulated in vitro with the specifi  c (SIINFEKL) or con-
trol (RAHYNIVTF) peptide and analyzed via IFN-γ ELISPOT.
ELISPOT assay. MultiScreen HA plates (Millipore) were coated with 
and blocked with phosphate-buff  ered saline with 1% bovine serum albumin 
before plating. Spleen and lymph node cells were plated at 2.5 × 105 
cells/well with HL-1 (Cambrex) supplemented with 2 mM l-glutamine, 
200 U/ml penicillin, and 50 μg/ml streptomycin. Cells were stimulated 
with either 10 μM OVA257–264 or bovine serum albumin for 48 h. The cells 
were treated with 1 μg/ml biotinylated anti–mouse–IFN-γ (XMG1.2; 
BD Bioscience) and a 1:1,000 dilution of streptavidin–alkaline phosphatase JEM VOL. 204, June 11, 2007  1473
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conjugate and developed with 5-bromo-4-chloro-3-indolyl phosphate/
nitroblue tetrazolium (Pierce Chemical Co.). The spots per well were 
manually counted.
Antigen-specifi   c and nonspecifi  c  CD4+ T cell proliferation. The 
MHC class II–restricted OVA T cell transgenic mouse strain DO11.10 was 
used to determine whether GR-1+ cells suppress antigen-specifi  c or nonspe-
cifi  c CD4+ T cell proliferation. DO11.10 transgenic mice were made septic 
and immunized with 100 μg OVA323–339 peptide (Genscript) in alum. At day 7, 
erythrocyte-depleted splenocytes and lymph node cells underwent CD4+ 
T cell purifi  cation by positive selection (>98% purity). The negative frac-
tion was irradiated with 3,000 rads. 2 × 105 antigen-presenting cells from 
sham-treated mice (containing <104 GR-1+ cells) or 2 × 105 antigen-pre-
senting cells from septic mice (containing 7.5 × 104 GR-1+ cells) were 
mixed with 2.5 × 104 CD4+ T cells. Cells were restimulated with 10 μg/ml 
OVA323–339 peptide or 1 μg/ml anti-CD3, and 1 μg/ml anti-CD28 or 
10 μg/ml of bovine serum albumin for 48 h. In the fi  nal 16 h of culture, 
1 μCi [3H]thymidine (GE Healthcare) was added. Proliferation was deter-
mined by the incorporation of [3H]thymidine in the cell co-culture.
Immunization with NP-KLH and humoral immune responses. An 
NP-KLH immunization model was used, as described by Hurov et al. (33). 
When indicated in the fi  gures, animals were depleted either of GR-1+ cells 
or CD4+ T cells by i.p. injection of purifi  ed rat anti–mouse GR-1 hybrid-
oma IgG1 (RP865) or rat anti–mouse CD4 hybridoma IgG1 (GK1.5). At day 
10 after surgery, mice were immunized s.c. with 100 μg of the T cell–
dependent antigen NP-KLH (Biosearch Tech) and alum. Serum titers of NP-
specifi  c antibodies were determined by ELISA. 96-well plates (Immulon 
4HBX; Dynex Tech) were coated with 1 mg of NP–bovine serum albumin 
(Biosearch Tech) per milliliter. NP-specifi  c antibodies were bound to bio-
tin-conjugated goat anti–mouse Ig isotype antibodies, anti-IgM, anti-IgG1, 
anti-IgG2a, and anti-IgG3 (CalTag). Streptavidin-conjugated horseradish 
peroxidase was incorporated to detect the biotin-Ig with 2,2′-azino-di(3-
ethylbenzthiazolinesulfonate) substrate.
Morphologic and histologic analysis. For cytospins, 105 enriched GR-
1+ splenocytes were stained using One Step II Wright-Giemsa Stain Solu-
tion (Criterion Sciences). Hematoxylin and eosin staining tissues were fi  xed 
in 10% neutral buff  ered formalin with 0.03% eosin (Sigma-Aldrich), paraffi   n 
embedded, sectioned (5-μm sections), and mounted for staining. For im-
munohistochemical staining, spleens were mounted in Tissue Tek optimum 
cutting temperature compound (Sakura Finetek) and fl  ash frozen. 4-μm 
cryosections were stained with a rat anti–mouse CD11b at a 1:50 dilution 
(BD Biosciences), followed by a biotinylated rabbit anti–rat (Vector Labora-
tories) secondary antibody, and visualized using Vulcan Fast Red (Biocare 
Medical). Slides were counterstained with hematoxylin (Vector Laborato-
ries), followed by bluing with Tris-buff  ered saline.
Statistics. Continuous variables were fi  rst tested for normality and equality 
of variances. Diff  erences among groups in fl  ow cytometric analyses were 
evaluated by analysis of variance for multiple groups and the Student’s t test 
for two groups. Signifi  cance was designated at the 95% confi  dence level.
Online supplemental material. Fig. S1 relates the bacteremia and blood 
leukocyte responses to sepsis produced by cecal ligation and puncture. Fig. 
S2 displays the mouse diff  erential white blood cell counts in response to 
sepsis. Fig. S3 exhibits the selected plasma cytokine concentrations in septic 
and sham-treated mice. Fig. S4 shows the splenomegaly that results from 
sepsis. Fig. S5 depicts the Ter119 surface staining of GR-1+CD11b+ sple-
nocytes harvested from sham and septic mice. Fig. S6 relates the MHC 
class II expression in GR-1+CD11b+ splenocytes harvested from sham 
and septic mice. Fig. S7 details the eff  ect of GR-1 antibody depletion on 
CD11b+GR-1+ populations in the spleen and lymph nodes. Fig. S8 de-
picts the immunoglobulin production after NP-KLH immunization in sham 
and septic mice. Fig. S9 exhibits the immunoglobulin production after NP-
KLH immunization in sham and septic mice 12 wk after cecal ligation and 
puncture. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20062602/DC1.
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